TB-500 (Thymosin Beta-4) is a 4.96 kDa actin-sequestering peptide that orchestrates cellular migration, angiogenesis, and inflammation control across multiple tissue types, with documented efficacy in cardiac, neural, dermal, and musculoskeletal repair
Graphical abstract Access this article Similar content being viewed by others References Li H, Eddaoudi M (1999) Design and synthesis of an exceptionally stable and highly porous metal-organic framework
The most common user-reported experience: Temporary skin dryness in week 1 (resolves by week 2) Occasional injection site redness (standard for any subQ peptide) Some users report increased hair growth, including in unintended areas at higher doses At doses above 34 mg/day, some protocols note headaches, but this is well above standard dosing
I've also seen employers add GLP-1 coverage mid-year when employees made a strong case about productivity and healthcare cost savings." 8